Menu
Back to Journals » OncoTargets and Therapy » Volume 8
Original Research
BMS-536924, an ATP-competitive IGF-1R/IR inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,802 | Dovepress* | 11,728+ | 1,648 | 13,376 | |
| PubMed Central* | 1,074 | 272 | 1,346 | ||
| Totals | 12,802 | 1,920 | 14,722 | ||
|
*Since 2 April 2015 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar